Current position:Home >Product >
N-(3-((4-Amino-6,7-dimethoxyquinazolin-2-yl)methylamino)propyl)furan-2-carboxamide
N-(3-((4-Amino-6,7-dimethoxyquinazolin-2-yl)methylamino)propyl)furan-2-carboxamide(98902-36-4)
- Name: N-(3-((4-Amino-6,7-dimethoxyquinazolin-2-yl)methylamino)propyl)furan-2-carboxamide
- Synonyms:N-(3-((4-Amino-6,7-dimethoxyquinazolin-2-yl)methylamino)propyl)furan-2-carboxamide;98902-36-4;UNII-Z6K8U43RQF;Z6K8U43RQF;Alfuzosin hydrochloride impurity A;Alfuzosin hydrochloride impurity A [EP];2-Furancarboxamide, N-(3-((4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)-;N-[3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)-methylamino]propyl]furan-2-carboxamide;SCHEMBL5462447;CHEMBL1191754;DTXSID50243869;Q27295072;ALFUZOSIN HYDROCHLORIDE IMPURITY A [EP IMPURITY]
- Molecular Formula:C19H23N5O4
- Molecular Weight:385.4
- CAS Registry Number:98902-36-4
- EINECS:689-750-3
- Melting Point:
- Water Solubility:
CAS No.98902-36-4 N-(3-((4-Amino-6,7-dimethoxyquinazolin-2-yl)methylamino)propyl)furan-2-carboxamide
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:N-(3-((4-Amino-6,7-dimethoxyquinazolin-2-yl)methylamino)propyl)furan-2-carboxamide
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.98902-36-4 Alfuzosin EP Impurity D
Assay:95%+ or 98%+ Appearance:solid Package:10mg/25mg/50mg/100mg/1000mg/5000mg Storage:short-term storage normal temperature. long-term storage 2-8 鈩?nbsp;Transportation:express and sea transport and air freight Application:for drug impurity for drug standards,for drug research and development銆侱rug impurity reference, drug standard, analytical chemistry, standard substance, organic chemical synthesis, chemical custo...
Min. Order:0
Supplier:Hubei Moxin Biotechnology Co., Ltd [
China (Mainland)]
Other Product
- 946681-95-4/3-(4-Bromo-2-fluorophenoxy)pyrrolidine
- 6622-67-9/Sulfuric acid--1-(2-butoxyphenyl)-4-(prop-2-en-1-yl)piperazine (1/1)
- 1233501-65-9/cis-1-tert-Butyl 3-ethyl 4-aminopyrrolidine-1,3-dicarboxylate hydrochloride
- 2648641-36-3/Zotizalkib
- 1346747-65-6/N-Methyl valacyclovir
- 1395408-54-4/Ethoxyparoxetine
- 171370-55-1/Delphinidin 3-arabinoside
- 1147107-63-8/4-(Ethanesulfonyl)piperidine hydrochloride
- 6274-80-2/Amino(tridecylamino)methaniminium hydrogensulfate
- 1341036-19-8/tert-Butyl 9-(hydroxymethyl)-3-azaspiro-[5.5]undecane-3-carboxylate
- 1361115-82-3/2'-Chloro-1-methyl-1,2,3,4,5,6-hexahydro-[4,4']bipyridinyl formic acid salt
- 799812-63-8/(2S,3R,4E)-2-Azaniumyl-3-hydroxy-18-({5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoyl}amino)octadec-4-en-1-yl hydrogen phosphate
- 861208-11-9/9-(4-fluorophenyl)[1,3]dioxolo[4,5-g]furo[3,4-b]quinolin-8(6H)-one
- 1811539-42-0/2,5-Dioxo-1-pyrrolidinyl3',6'-di-1-azetidinyl-2-diazo-2,3-dihydro-3-oxospiro[1H-indene-1,9'-[9H]xanthene]-6-carboxylate
- 286936-40-1/Acetamide, 2,2',2'',2'''-(pentacyclo(19.3.1.13,7.19,13.115,19)octacosa-1(25),3,5,7(28),9,11,13(27),15,17,19(26),21,23-dodecaene-25,26,27,28-tetrayltetrakis(oxy))tetrakis(N-(2-(dimethylamino)ethyl)-
- 1261986-64-4/3-(4-Hydroxymethylphenyl)-2-methoxybenzoic acid
- 908305-13-5/Epertinib
- 1831116-77-8/S-222611
- 752982-24-4/2,5-Dimethoxy-4-ethynylphenethylamine
- 98902-36-4/N-(3-((4-Amino-6,7-dimethoxyquinazolin-2-yl)methylamino)propyl)furan-2-carboxamide
- 93322-73-7/3-(8-Methoxy-4,14-dioxo-3,11,13-trioxatetracyclo[8.6.0.02,7.012,16]hexadeca-1,5,7,9-tetraen-6-yl)propanoic acid
- 1188964-82-0/N-Methyltetrahydro-2H-thiopyran-4-amine hydrochloride
- 326495-40-3/(2R)-2,3-Bis[(~2~H_35_)octadecanoyloxy]propyl 2-{tris[(~2~H_3_)methyl]azaniumyl}(~2~H_4_)ethyl phosphate
- 1374659-30-9/2,5-Dichloro-4-(difluoromethyl)pyridine
- 1151517-98-4/Cetyldimonium ethyl cetyl phosphate
- 1094672-99-7/2-(3-Formylphenoxy)-2-phenylacetic acid
- 773129-02-5/3-(3-Bromo-5-chloro-2-hydroxyphenyl)prop-2-enoic acid
- 1220020-06-3/N-(3-Methylphenyl)-3-piperidinecarboxamide hydrochloride
- 1310404-31-9/2-(4-Bromothiophen-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
- 1449008-15-4/5-Bromo-3-chloro-2-fluorobenzoic acid